Emami Ltd Q2 FY26: Cooling Oils, Cooling Sales, and a Warm Dividend — FMCG Royalty Faces a Prickly Quarter
1. At a Glance
Emami Ltd — the FMCG patriarch that’s been cooling India’s heads with Navratna Oil and heating its margins with BoroPlus balm — has hit a slippery patch this quarter. In Q2 FY26, consolidated revenue fell 10.3% YoY to ₹799 crore, while PAT tumbled 30.2% to ₹148 crore. The operating profit margin melted from 23% to 22%, like Navratna oil under a desert sun.
The stock, lounging at ₹525 (down nearly 22% in a year), is now trading at a P/E of 30.4, which is still far more expensive than the average Indian midlife crisis, but cheaper than most FMCG bluebloods like Dabur and Godrej Consumer. Market cap stands at ₹22,923 crore, with a ROE of 30.2%, ROCE of 32.4%, and a dividend yield of 1.53%.
And because Emami knows how to keep shareholders happy when customers aren’t buying enough balm, it’s announced an interim dividend of ₹4 per share (400%), record date November 14, 2025. Classic Emami move — a warm pat on the back while sales take a cold shower.
2. Introduction – The House of Balms, Blessings, and Brand Power
Few Indian FMCG companies can brag about being in every Indian household bathroom and first-aid box — and then get roasted in the same breath for relying too much on summer.
From BoroPlus to Navratna, Zandu Balm to Fair and Handsome, Emami has been the granddad of personal care, the Ayurvedic whisperer who knows the pain points of both consumers and investors. The company, founded by Kolkata’s Goenka-Agarwal duo, has built a ₹3,700 crore revenue empire out of itch relief, hair fall panic, and seasonal sweat management.
But the FY26 story isn’t about comfort — it’s about cold numbers. Sales down, profits down, yet margins somehow surviving. While peers like Dabur and P&G Hygiene are fighting their own monsoons, Emami’s problem is specific: a heavy summer-centric product mix and rural slowdown, both of which have turned the once-sizzling cooling oil portfolio into a mild breeze.
Still, Emami’s resilience shows in its 25% operating margins and its willingness to spend nearly 18% of revenue on advertising. That’s right — the company is spending more on celebrities than some Bollywood producers. When you have 100+ brand ambassadors, even the recession starts looking like a brand collab opportunity.
3. Business Model – WTF Do They Even Do?
Emami’s business is a perfect cocktail of Ayurveda, nostalgia, and aggressive marketing. It’s divided broadly into two categories — Personal Care (BoroPlus, Navratna, Fair & Handsome, Kesh King) and Healthcare (Zandu Balm, Pancharishta, Chyawanprash) — all marinated in celebrity glamour and backed by deep distribution.
Here’s how the empire breaks down:
BoroPlus (Antiseptic Range): Dominates its category with a 67.7% market share. Whether it’s cracks, cuts, or “winter skin drama,” this is Emami’s reliable money balm.
Navratna & Dermicool: The cooling oil + talc segment accounts for over 60% of market share. Unfortunately, a delayed summer or low rural income can make this product line sweat.
Pain Management (Zandu, Mentho Plus, Fast Relief): A solid 54% market share, powered by every Indian uncle’s aching back.
Kesh King: India’s favorite hair fall control oil with 29.4% share, a rare bright spot where Ayurvedic promise still drives revenue.
Smart & Handsome: The rebranded Fair & Handsome continues its dominance with 67.3% share in men’s fairness cream (because patriarchy sells creams too).
The Man Company & Brillare: The premium, urban avatar — Emami now owns 100% of Helios Lifestyle, betting big on modern male grooming.
The company’s distribution muscle — 4,000+ distributors, 4.9 million outlets, 70+ countries — ensures its creams and oils reach from Chhapra to Cairo. However, 84% of revenue still comes from India, so when rural demand sneezes, Emami catches a cold.
4. Financials Overview
Consolidated Quarterly Snapshot (₹ crore)
Metric
Q2 FY26 (Sep 2025)
Q2 FY25 (Sep 2024)
Q1 FY26 (Jun 2025)
YoY %
QoQ %
Revenue
799
891
904
-10.3%
-11.6%
EBITDA
177
246
212
-28.0%
-16.5%
PAT
148
211
164
-30.0%
-9.8%
EPS (₹)
3.40
4.87
3.76
-30.2%
-9.6%
Commentary: Sales cooled faster than Navratna oil in a Himalayan breeze. Despite a loyal balm army, rural weakness hit the FMCG cycle hard. Even other income (₹21 crore) couldn’t rescue the quarter. But the bright side — Emami still maintains fat 25%+ margins that most FMCG rivals would sell their hair oil for.
5. Valuation Discussion – Fair Value Range
Let’s do some quick math before the fairness cream runs out:
EPS (TTM): ₹17.3
Current Price: ₹525
P/E Method: At 25x to 32x P/E (reasonable FMCG band), fair value range = ₹432 – ₹554.
EV/EBITDA:
EV = ₹22,766 crore
EBITDA (TTM) = ₹1,014 crore
EV/EBITDA = 22.4x (already at upper mid-cap FMCG levels). Fair EV/EBITDA range for FMCG = 18x–24x → Fair Value Range ≈ ₹450 – ₹540.
